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Abstract 
Objective. To evaluate diagnostic test accuracy of ultrasonography (US) compared with magnetic 
resonance imaging (MRI) for the detection of synovitis in rheumatoid arthritis (RA) patients. 
Methods. A systematic literature search was performed in the Pubmed, EMBASE, the Cochrane Library, 
and Web of Science Core Collection. Studies evaluating diagnostic test accuracy of US for synovitis 
detected by MRI as the reference standard for wrist, metacarpophalangeal (MCP), proximal interphalangeal 
(PIP), and knee joints were included. To assess the overall accuracy, we calculated the diagnostic odds ratio 
(DOR) using a DerSimonian-Laird random-model and area under the hierarchical summary receiver 
operating characteristics (AUC) using Holling's proportional hazard models. The summary estimate of the 
sensitivity and the specificity were obtained using the bivariate model. 
Results. Fourteen of 601 identified articles were included in the review. The DOR was 11.6 (95%CI 5.6-
24, I2 = 0%), 28 (95%CI 12-66, I2 = 11%), 23 (95%CI 6.5-84, I2 = 19%), 5.3 (95%CI 0.60-48, I2 = 0%) and 
AUC was 0.81, 0.91, 0.91, 0.61, for wrist, MCP, PIP, and knee joints, respectively. The summary estimate 
of sensitivity and specificity were 0.73 (95%CI 0.51-0.87)/0.78 (95%CI 0.46-0.94), 0.64 (95%CI 0.43-
0.81)/0.93 (95%CI 0.88-0.97), 0.71 (95%CI 0.33-0.93)/0.94 (95%CI 0.89-0.97), and 0.91 (95%CI 0.56-
0.99)/0.60 (95%CI 0.20-0.90) for wrist, MCP, PIP, and knee joints, respectively. 
Conclusion. US is a valid and reproducible technique for detecting synovitis in the wrist and finger joints. 
It may be considered for routine use as part of the standard diagnostic tool in RA. 
Introduction 
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by autoimmunity and 
polyarticular synovial inflammation; it subsequently causes bone destruction. For patients with RA the 
current concept is "treat-to-target" with clinical remission the primary treatment goal aiming to achieve it 
as soon as possible [1]. Clinical trials have demonstrated that early treatment reduces inflammation, 
resulting in limited structural change and better long-term outcomes [2-6]. Therefore, early diagnosis of 
RA is essential for initiation of treatment. Recently, advances in the field of imaging techniques have 
resulted in ultrasonography (US) and magnetic resonance imaging (MRI) being recommended for making 
the diagnosis and monitoring the disease activity in RA patients [7]. US and MRI have been shown to be 
more sensitive than clinical examination in detecting synovitis, both in active disease and in remission. [8-
10]. The predictive value of evaluating subclinical synovitis by imaging techniques was first described by 
Brown et al [11] and it has been demonstrated that US-detected subclinical synovitis can lead to 
radiographic progression, even in clinical remission [12]. Moreover, the presence of inflammation observed 
with US or MRI can be used to predict the progression from undifferentiated inflammatory arthritis to 
clinical RA [13-16]. 
Although MRI is capable of directly visualising joint inflammation, there are difficulties in performing 
MRI as an initial test because of the limited resources. The assessment of multiple joints with MRI is time-
consuming and expensive for routine use. By contrast, US is relatively low-cost, non-invasive, and has real-
time capabilities and portability. Despite these advantages, there are some limitations of this technology, 
whilst several studies have highlighted the ability of US in the detection of joint inflammation as compared 
with MRI, there was considerable discrepancy of results in these previous studies, and US is considered to 
be an operator-dependent technology. To assist in resolving this discrepancy, this systematic review and 
meta-analysis was conducted. 
  
Methods 
Overview 
    The study protocol followed the Cochrane Handbook for Diagnostic Test Accuracy Review and the 
Preferred Reporting Items in Systematic Reviews, and the Meta-analysis statement has been registered on 
the international prospective register of systematic reviews (PROSPERO) as number 42016033912 [17-20]. 
Institutional Review Board approval and patient informed consent were waived due to review nature of this 
study. 
    Both case-control and cohort studies were included when they provided sufficient data for both 
sensitivity and specificity of US for detection of MRI-judged synovitis in human RA. However, no eligible 
case-control study were found. Here, single- and two-gate studies were customarily termed cohort and case-
control studies. Studies covering only sensitivity or only specificity were excluded. Non-English written 
reports and conference abstracts were allowed in the protocol, though none of them were eventually eligible. 
 
Search strategy 
In the electronic search, we systematically searched Pubmed, EMBASE, the Cochrane Central 
Register of Controlled Trials, and Web of Science Core Collection. Search formulas were presented as 
supplementary data (Supplementary Text 1). References of previously published reviews and those of 
included original studies were checked through the hand search. Two investigators (KM, NH) 
independently screened the candidate articles by checking the title and abstract after uploading the citation 
list into the software, Endnote X7 (Thomson Reuters, Philadelphia, USA). After independent screening, 
articles still regarded as candidates by at least one investigator were then scrutinised independently through 
full-text reading. Final inclusion were decided after resolving discrepancies between the two investigators. 
 
Participants 
We included patients with the diagnosis of RA defined by the 2010 American College of 
Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria or 1987 
ACR criteria for RA [21, 22]. Synovitis in RA at wrist joints, metacarpophalangeal (MCP) joints, proximal 
interphalangeal (PIP) joints, and knee joints were the target pathology. Neither bone erosion nor synovitis 
that was caused by connective tissue diseases other than RA was included in this study.  
 
Index and reference test 
The index test was US in any mode including color Doppler US, power Doppler US, B-mode US, grey 
scale US, 2D US, 3D US, and contrast-enhanced US [23]. Positive and negative results for US were 
determined based on judgement by the authors of the original researches. When a report presented 
diagnostic test accuracy of two US modes separately, we used the only data of PD to avoid duplicate use of 
the data from the same subject. In such a case, we selected PD rather than GS because recent data suggested 
that PD can provide more accurate data than GS for synovitis in RA [7]. 
Reference test were MRI in any mode including non-enhanced MRI, enhanced MRI, dynamic MRI, 
1.5-Tesla MRI, and 3-Tesla MRI, compact MRI, low-field extremity MRI, 0.2-Tesla MRI [24]. Positive 
and negative result in MRI were also determined based on judgement by the authors of the original 
researches. We categorised the quality of MRI based on MRI mode as follows: high = high field contrast-
enhanced MRI, moderate = high agreement was confirmed in comparison with high field contrast-enhanced 
MRI, low = low field extremity MRI. Four cohorts, using MRI without contrast enhancement, evaluated 
the ability to detect synovitis in comparison with conventional 1.5 T contrast-enhanced MRI in RA patients 
in a preliminary study [33, 35, 41]. Therefore, we defined “moderate quality”. 
 
Primary outcome 
Co-primary outcomes were diagnostic test accuracy of US for synovitis diagnosed by MRI using 
following statistics: diagnostic odds ratio (DOR), area under hierarchical summary receiver operating 
characteristic (HSROC) curve (AUC), the summary estimates of the sensitivity, the specificity, the positive 
likelihood ratio (PLR), and the negative likelihood ratio (NLR). Wrist, MCP, PIP, and knee joints were 
evaluated separately [17, 18]. 
 
Risk of bias 
The two investigators independently evaluated each study by scoring seven domains of A Revised 
Tool for the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) evaluation sheet [25]. Any 
discrepancies were resolved through discussion. 
 
Data synthesis 
Data were crosschecked after extracted by the two investigators independently. Then, we composed a 
two by two contingency. 
All analyses were done based on numbers of joints but not on numbers of patients. 
We used both the HSROC model and bivariate model. To determine the overall diagnostic test accuracy, 
we calculated the DOR using the DerSimonian-Laird random-effect model and the AUC using bivariate 
model of Reitsma [26, 27]. Heterogeneity was indicated by I2 wherein 0% means no heterogeneity and 
100% means the strongest heterogeneity. We obtained a paired forest plot, HSROC curve, and summary 
estimates of the sensitivity and the specificity using the bivariate model. PLR and NLR were obtained using 
the summary estimate of the sensitivity and the specificity [26, 27]. DOR, AUC, and HSROC were obtained 
from all the cohorts regardless of the cut-off value. Summary estimates of the sensitivity, summary estimate 
of specificity, PLR, and NLR were obtained from cohorts that used US cutoff values between negative and 
positive. According to the authors, five adaptive cutoff scores of US were used as follows: (1) 0 grouped as 
“negative”, 1 grouped as “positive”; (2) 0 grouped as “negative”, 1-2 grouped as “positive”; (3) 0 grouped 
as “negative”, 1-3 grouped as “positive”; (4) 0-1 grouped as “negative”, 2-3 grouped as “positive”; (5) 0-1 
grouped as “negative”, 2-4 grouped as “positive”. 
We conducted subgroup analyses based on US modes and MRI modes. 
We used the following commands in the "mada" package of the statistics software R: the “madauni” 
command for DOR and the “reitsma” command for the AUC, the HSROC curve, the summary estimates 
of sensitivity and specificity [26, 27]. Review Manager 5.3 (Cochrane, London, UK) was used to draw the 
paired forest plot and the Cochrane risk of bias graph. 
 
Interpretation of diagnostic test accuracy statics 
AUC was interpreted in a four-grade scale as follows: AUC < 0.75 not accurate, 0.75 < AUC < 0.92 
good, 0.93 < AUC < 0.96 very good, AUC < 0.97 excellent [28]. PLR value in the range of < 2, between 2 
and 5, between 5 and 10, and > 10 were recognised as a not meaningful, small, moderate, and large increase 
in probability [29]. NLR in the range of > 0.5, between 0.2 and 0.5, between 0.1 and 0.2, and < 0.1 were 
interpreted as a not meaningful, small, moderate, and large decrease of probability [29]. 
 
  
Results 
Study search and study characteristics 
    Of the 601 candidate articles, we finally identified 14 eligible reports [30-43]. Three of them presented 
two cohorts, thus we included 17 independent cohorts (Figure 1). To obtain data that were not presented in 
each original report, we tried to have a contact with authors of 18 reports. Among them, authors of 3 original 
reports provided additional information [32-34]. 
    Among the included 14 reports, six were from Japan, four were from Denmark, and one were from 
each of Belgium, China, Germany, and UK. Publication dates ranged from 2001 to 2014. All reports used 
one-gate cohort recruiting method (Table 1). One was English written letter and the other were English full 
articles. Seven, three, and one were conducted in single university hospital, in multi-center hospital-based 
arthritis clinics, and in single hospital respectively, while three reports did not provide specific information 
of their facility. To diagnose RA, one used both 1987 ACR criteria and 2010 ACR/EULAR criteria, 12 used 
1987 ACR criteria only, and one did not provided the information of diagnostic criteria. Numbers of patients 
in each study ranged from 6 to 77 with a median of 18, with a total of 376 (Table 1). Concerning Cochrane 
risk of bias evaluation, one study had high risk of index bias due to arbitrary decision of US cutoff [36]. No 
other report had any high risk of bias or any high applicability concern (Supplementary Figure 1). 
Among 17 cohorts, 12 used non-enhanced power Doppler, three used grey-scale US, one used 
contract-enhanced power Doppler, one used both grey-scale US and power Doppler. Wrist, MCP, PIP, and 
knee joint were evaluated in five, 12, six, and two cohorts, respectively and were evaluated for 275, 2060, 
1073, and 31 joints, respectively (Table 2). Median sensitivities/specificities were 0.66/0.90, 0.77/0.96, 
0.80/0.91, and 0.77/0.55 for wrist, MCP, PIP, and knee joints, respectively (Figure 2). 
 
Wrist 
    Five cohorts with 275 wrist joints yielded DOR of 11.6 (95%CI 5.6-24, I2 = 0%) and AUC of 0.81. 
This AUC suggested that US had good diagnostic test accuracy for wrist synovitis (Figure 3, Table 2). 
Using the cutoff value between absence and presence, the summary estimate of sensitivity and 
specificity were 0.73 (95%CI 0.51-0.87) and 0.78 (95%CI 0.46-0.94), respectively. Based on PLR of 3.3 
and NPV of 0.35, both positive and negative US results suggested a small change of synovitis probability 
(Table 2 A). 
 
MCP 
    Data of 2060 MCP joints from 12 cohorts suggested DOR of 28 (95%CI 12-66, I2 = 11%) and AUC 
of 0.91, which meant that US had good diagnostic test accuracy for MCP synovitis (Figure 3, Table 2).  
    When applying the cutoff value between absence/presence, the summary estimate of sensitivity and 
specificity were 0.64 (95%CI 0.43-0.81) and 0.93 (95%CI 0.88-0.97), respectively (Table 2). PLR was 9.1 
(95%CI 4.2-19) suggesting moderate increase of MCP synovitis probability when US detected it. 
 PIP 
    Six cohorts of 1073 PIP joints yielded a DOR of 23 (95%CI 6.5-84, I2 = 19%) and AUC of 0.91. This 
AUC value suggested that US had good diagnostic test accuracy for PIP synovitis (Figure 3, Table 2).  
Using the data from five cohorts that used a cut-off value between absence/presence, the summary 
estimate of sensitivity and specificity were 0.71 (95%CI 0.33-0.93) and 0.94 (95%CI 0.89-0.97), 
respectively. Positive and negative US results suggested large and small change of synovitis probability, 
respectively (Table 2). 
 
Knee 
    The diagnostic test accuracy of knee was researched in a smaller number of cohorts and joints 
compared to other joints. DOR was 5.3 (95%CI 0.60-48, I2 = 0%) and AUC was 0.61, which indicated that 
the US did not have good diagnostic test accuracy for knee synovitis (Figure 3, Table 2). The 95% CI of 
both PLR and NLR included 1.0, which meant no diagnostic value. (Table 2). 
 
MRI mode subgroup analysis 
        We carried out subgroup analyses focusing on studies with high-quality MRIs and those with 
moderate- or high-quality MRIs. These analyses almost replicated the results from studies with any MRI 
modes (Supplementary Table 1). 
 
US mode subgroup analysis 
        Based on US mode subgroup analysis, power Doppler US showed better overall diagnostic 
testaccuracy than grey-scale US (Supplementary Table 2). Notably, power Doppler US had very good AUC 
to detect MRI proven synovitis in MCP and PIP joints. Power Doppler US positive with a cutoff value 
between absence/presence or 0/1 largely increase the probability of MRI proven synovitis in MCP and PIP 
joints (Supplementary Table 2). 
  
Discussion 
US is widely used for the evaluation of RA inflammatory activity in daily practice and in clinical trials. 
Despite the increasing availability of US application, there remains a lack of quality validation studies. The 
Outcome Measures in Rheumatology (OMERACT) group has proposed definitions for synovial fluid and 
synovial hypertrophy [44]. US allows visualisation of the pannus developing in the inflamed joint. Grey-
scale and Doppler US are capable of measuring synovial proliferation and vascularity, respectively. Several 
approaches for assessing synovitis in RA patients have been described in published studies. Qualitative, 
semiquantitative and scoring systems have been used for assessing synovitis by grey-scale and/or Doppler 
US. 
Our systematic review and meta-analysis provided the evidence supporting the use of US for 
evaluating synovitis in RA patients. MRI mode based subgroup analyses suggested the robustness of our 
analysis. We showed that the diagnostic test accuracy of US was good for detecting synovitis at joint level 
using MRI as the reference standard, especially with regard to MCP and PIP joints. The data suggest that 
US of wrist joints was less accurate than MCP and PIP joints. The diagnostic test accuracy for knee joints 
was low, but was based on a small number of cohorts. Although it has limited resolution for deeper joints 
and the patient’s body habitus may sometimes make examination difficult, US has been shown to be more 
sensitive than clinical examination in determining synovitis for large joints such as the shoulder and knee 
[45, 46]. The small sample size increased the size of confidence intervals, and therefore a greater statistical 
uncertainty of the results, even when the diagnostic test has a high sensitivity. 
This meta-analysis has several limitations. The number of papers qualifying for the analysis is low and 
we used data from direct communication with the original authors. Therefore, recall bias would occur. Our 
systematic review focused on wrist, finger and knee joints. As noted above, only two reports representing 
three cohorts compared the ability of US and MRI to detect synovitis for knee joints. However, the small 
joints of the hands and feet play a central role in the diagnosis of RA. Our systematic review shows that US 
can be recommended as a reliable diagnostic tool for synovitis in RA. Previous systematic review suggested 
that the wrist, MCP and metatarsophalangeal (MTP) joints should be scanned in the diagnostic process of 
RA [47]. Despite the fact that feet were not evaluated in this study, similar results may be obtained for MTP 
joints. As, MRI is not a gold standard to detect synovitis without contrast enhancement, we carried out 
subgroup analyses based on MRI quality. MRI is also reader-dependent particularly when an established 
scoring method such as RAMRIS is not used. Furthermore, subgroup analysis based on US mode showed 
Doppler US had very good diagnostic test accuracy and was more accurate than grey-scale US concerning 
detecting MCP synovitis. Some subgroup analyses provided imprecise estimation of test accuracy due to 
limited number of studies. 
Our systematic review did not distinguish early and established RA. In this meta-analysis, all of 
identified eligible studies were performed for established RA patients. Harman et al. assessed the efficacy 
of US compared with contrast-enhanced MR in patients with newly diagnosed RA [48]. However, as they 
showed only sensitivity and specificity data, this study was excluded. Another issue is operator-dependent 
techniques for scoring systems. Although US examination for synovitis is mostly carried out from the dorsal 
aspect of the finger joint, several studies have addressed volar synovitis. Moreover, our systematic review 
revealed a lack of consensus regarding standardised US scoring system for synovitis. The definition of a 
“positive” or “negative” US-determined synovitis was defined with different cut-off values. The sensitivity 
and specificity of a quantitative test are dependent on the cut-off value above or below, and there is a “trade-
off” between sensitivity and specificity. We chose the bivariate model to determine the overall diagnostic 
test accuracy of US. This model takes into account the potential trade-off between sensitivity and specificity 
by explicitly incorporating this negative correlation in the analysis, with the result it could calculate the 
DOR/AUC. However, the reliability of the estimated accuracy is limited, especially for knee, where only a 
limited number of studies is being present. In addition, the optimal cut-off value was not determined in this 
study. Although five adaptive cutoff scores were used, it was not enough to make the distinction at various 
cut-off scores due to the small sample size. 
In summary, this systematic review and meta-analysis suggest that US, especially power Doppler US, 
is a valid and reproducible technique for detecting synovitis in the wrist and finger joints. US has certain 
great advantages over MRI, including low cost, portability, and lack of contraindications. It requires 
consideration of appropriate training and quality assessment. However, US may allow more widespread, 
therefore be considered for routine use as part of the standard diagnostic tool in RA. 
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Rheumatology key messages 
This is the first systematic review and meta-analysis on US assessment of synovitis in RA patients. 
US seems a valid and reproducible technique for detecting synovitis in the wrist and finger joints. 
Further US quality assessment is necessary for diagnostic test accuracy. 
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Figure Legends 
Figure 1. PRISMA flow diagram. 
Figure 2. Paired forest plots. 
MCP: metacarpophalangeal. PIP: proximal interphalangeal. TP: true positive. FP: false positive. FN: false 
negative. TN: true negative. 
Figure 3. Hierarchical summary receiver operating characteristic curves. 
MCP: metacarpophalangeal. PIP: proximal interphalangeal. 
